Kauffman A
Endocrinology. 2024; 165(10).
PMID: 39207217
PMC: 11393496.
DOI: 10.1210/endocr/bqae113.
Liu P, Takahashi P, Roebuck P, Bailey J, Keenan D, Veldhuis J
J Clin Endocrinol Metab. 2009; 94(10):3978-86.
PMID: 19584190
PMC: 2758726.
DOI: 10.1210/jc.2009-0135.
Aiman J, Boyar R
Arch Sex Behav. 1982; 11(2):171-9.
PMID: 7125886
DOI: 10.1007/BF01541982.
Boyar R, Aiman J
Arch Sex Behav. 1982; 11(2):157-69.
PMID: 6812547
DOI: 10.1007/BF01541981.
Ruiz E, Ortega E, Sanchez-Cantalejo E, Osorio C
J Endocrinol Invest. 1980; 3(4):385-8.
PMID: 6782152
DOI: 10.1007/BF03349375.
Role of endogenous opiates in the expression of negative feedback actions of androgen and estrogen on pulsatile properties of luteinizing hormone secretion in man.
Veldhuis J, Rogol A, SAMOJLIK E, ERTEL N
J Clin Invest. 1984; 74(1):47-55.
PMID: 6429197
PMC: 425183.
DOI: 10.1172/JCI111417.
The role of testosterone in the feedback control of male FSH and LH secretion.
Borsch G, Mauss J, Richter E, Bormacher K, Leyendecker G, NOCKE W
Klin Wochenschr. 1975; 53(5):237-9.
PMID: 1152351
DOI: 10.1007/BF01468813.
Is aromatization of testosterone to estradiol required for inhibition of luteinizing hormone secretion in men?.
Santen R
J Clin Invest. 1975; 56(6):1555-63.
PMID: 1104659
PMC: 333134.
DOI: 10.1172/JCI108237.
Neuroendocrine effects of a non-steroidal compound of testicular origin.
ITURRIZA F, Carlini M, Piva F, Martini L
Experientia. 1977; 33(3):396-8.
PMID: 858378
DOI: 10.1007/BF02002849.
Male hypogonadism.
Odell W, Swerdloff R
West J Med. 1976; 124(6):446-75.
PMID: 820082
PMC: 1130101.
Gonadotrophin-releasing hormone.
Mortimer C, Yeo T
J Clin Pathol Suppl (Assoc Clin Pathol). 1976; 7:46-54.
PMID: 801478
PMC: 1436119.
DOI: 10.1136/jcp.s1-7.1.46.
5 alpha-reductase deficiency in humans: support to the theory that 5 alpha-reduction of testosterone is an essential step in the control of LH secretion.
Martini L, Celotti F, Serio M
J Endocrinol Invest. 1979; 2(4):463-4.
PMID: 536582
DOI: 10.1007/BF03349351.
